Be part of the knowledge.™

Neurology and Neurosurgery

830

LikeLikedUnlike

Episodes 16-30 of 94

MinuteCE®
Modern Neuromodulation: Vagus Nerve Stimulation in Advancing Care for Patients With Drug-Resistant Epilepsy and Treatment-Resistant Depression
- Raman Sankar, MD, PhD
  Peer
- Scott Aaronson, MD
  Peer
0.50 credits 5 episodes
Differentiating Neuromodulation Therapies: VNS, DBS, ECT, TMS
MinuteCE®
Differentiating Neuromodulation Therapies: VNS, DBS, ECT, TMS
- Raman Sankar, MD, PhD
  Peer
- Scott Aaronson, MD
  Peer
0.50 program credits
Epilepsy: Beyond Seizure Impact
MinuteCE®
Epilepsy: Beyond Seizure Impact
- Raman Sankar, MD, PhD
  Peer
- Scott Aaronson, MD
  Peer
0.50 program credits
VNS: Beyond Seizure Control
MinuteCE®
VNS: Beyond Seizure Control
- Raman Sankar, MD, PhD
  Peer
- Scott Aaronson, MD
  Peer
0.50 program credits
QoL Matters: Brain Stem Stimulation in Patients With Unipolar Depression
MinuteCE®
QoL Matters: Brain Stem Stimulation in Patients With Unipolar Depression
- Raman Sankar, MD, PhD
  Peer
- Scott Aaronson, MD
  Peer
0.50 program credits
Optimizing VNS Parameters: Keys to Therapeutic Success
MinuteCE®
Optimizing VNS Parameters: Keys to Therapeutic Success
- Raman Sankar, MD, PhD
  Peer
- Scott Aaronson, MD
  Peer
0.50 program credits
advertisement
The Latest in Stroke Risk Reduction Strategies: Are Your Patients Protected?
CME/CE
The Latest in Stroke Risk Reduction Strategies: Are Your Patients Protected?
- Alejandro A. Rabinstein, MD, FAHA
  Peer
- Richard E. Pratley, MD
  Peer
- Jay H. Shubrook, DO, FACOFP, FAAFP
  Peer
1.00 credits
Driving Progress in Cardiology: Exploring the Role of FXI in Acute Coronary Syndromes & Beyond
CME/CE
Driving Progress in Cardiology: Exploring the Role of FXI in Acute Coronary Syndromes & Beyond
- C. Michael Gibson, MD, MS
  Peer
- Roxana Mehran, MD, FSCAI
  Peer
1.00 credits
New Frontiers in the Treatment of DMD Across the Age Spectrum
CME/CE
New Frontiers in the Treatment of DMD Across the Age Spectrum
- Crystal Proud, MD
  Peer
- John Brandsema, MD
  Peer
- Omer Abdul Hamid, MD
  Peer
1.00 credits
Treatment Advances in Generalized Myasthenia Gravis: A Pathophysiology-Driven Framework Leveraging FcRn Therapeutics
CME/CE
Treatment Advances in Generalized Myasthenia Gravis: A Pathophysiology-Driven Framework Leveraging FcRn Therapeutics
- Vera Bril, MD
  Peer
- Neelam Goyal, MD
  Peer
0.75 credits
MinuteCE®
Treatment Advances in Generalized Myasthenia Gravis: Addressing the Nuances of its Underlying Immunopathology
- Vera Bril, MD
  Peer
- Nicholas J. Silvestri, MD
  Peer
- Hans Katzberg, MD
  Peer
1.00 credits 10 episodes
Treatment Advances in Generalized Myasthenia Gravis: Clinical and Laboratory Criteria for Diagnosis and Optimal Treatment Selection
CME/CE
Treatment Advances in Generalized Myasthenia Gravis: Clinical and Laboratory Criteria for Diagnosis and Optimal Treatment Selection
- Vera Bril, MD
  Peer
- Jonathan Strober, MD
  Peer
0.75 credits
advertisement
Living with gMG: Navigating Personal, Professional, and Mental Health Challenges
MinuteCE®
Living with gMG: Navigating Personal, Professional, and Mental Health Challenges
- Vera Bril, MD
  Peer
- Nicholas J. Silvestri, MD
  Peer
1.00 program credits
Diagnostic Advances in gMG: Effective Tools and Techniques
MinuteCE®
Diagnostic Advances in gMG: Effective Tools and Techniques
- Vera Bril, MD
  Peer
- Hans Katzberg, MD
  Peer
1.00 program credits
Autoantibodies Explained: Anti-AChR, Anti-MuSK, and Their Diagnostic Role
MinuteCE®
Autoantibodies Explained: Anti-AChR, Anti-MuSK, and Their Diagnostic Role
- Vera Bril, MD
  Peer
- Nicholas J. Silvestri, MD
  Peer
1.00 program credits

Program Chapters

Segment Chapters

Playlist:

Recommended